178 related articles for article (PubMed ID: 38483989)
21. Mutations Utilize Dynamic Allostery to Confer Resistance in TEM-1 β-lactamase.
Modi T; Ozkan SB
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30501088
[TBL] [Abstract][Full Text] [Related]
22. Elucidating the Role of Residue 67 in IMP-Type Metallo-β-Lactamase Evolution.
LaCuran AE; Pegg KM; Liu EM; Bethel CR; Ai N; Welsh WJ; Bonomo RA; Oelschlaeger P
Antimicrob Agents Chemother; 2015 Dec; 59(12):7299-307. PubMed ID: 26369960
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the functional contributions of Asn233 in metallo-β-lactamase IMP-1.
Brown NG; Horton LB; Huang W; Vongpunsawad S; Palzkill T
Antimicrob Agents Chemother; 2011 Dec; 55(12):5696-702. PubMed ID: 21896903
[TBL] [Abstract][Full Text] [Related]
24.
Barnes MD; Winkler ML; Taracila MA; Page MG; Desarbre E; Kreiswirth BN; Shields RK; Nguyen MH; Clancy C; Spellberg B; Papp-Wallace KM; Bonomo RA
mBio; 2017 Oct; 8(5):. PubMed ID: 29089425
[TBL] [Abstract][Full Text] [Related]
25. Network models of TEM β-lactamase mutations coevolving under antibiotic selection show modular structure and anticipate evolutionary trajectories.
Guthrie VB; Allen J; Camps M; Karchin R
PLoS Comput Biol; 2011 Sep; 7(9):e1002184. PubMed ID: 21966264
[TBL] [Abstract][Full Text] [Related]
26. Comparative Characterization of CTX-M-64 and CTX-M-14 Provides Insights into the Structure and Catalytic Activity of the CTX-M Class of Enzymes.
He D; Chiou J; Zeng Z; Chan EW; Liu JH; Chen S
Antimicrob Agents Chemother; 2016 Oct; 60(10):6084-90. PubMed ID: 27480856
[TBL] [Abstract][Full Text] [Related]
27. Mutagenesis of zinc ligand residue Cys221 reveals plasticity in the IMP-1 metallo-β-lactamase active site.
Horton LB; Shanker S; Mikulski R; Brown NG; Phillips KJ; Lykissa E; Venkataram Prasad BV; Palzkill T
Antimicrob Agents Chemother; 2012 Nov; 56(11):5667-77. PubMed ID: 22908171
[TBL] [Abstract][Full Text] [Related]
28. Mutation of the active site carboxy-lysine (K70) of OXA-1 beta-lactamase results in a deacylation-deficient enzyme.
Schneider KD; Bethel CR; Distler AM; Hujer AM; Bonomo RA; Leonard DA
Biochemistry; 2009 Jul; 48(26):6136-45. PubMed ID: 19485421
[TBL] [Abstract][Full Text] [Related]
29. A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance.
Stürenburg E; Kühn A; Mack D; Laufs R
J Antimicrob Chemother; 2004 Aug; 54(2):406-9. PubMed ID: 15201232
[TBL] [Abstract][Full Text] [Related]
30. Mapping the determinants of catalysis and substrate specificity of the antibiotic resistance enzyme CTX-M β-lactamase.
Judge A; Hu L; Sankaran B; Van Riper J; Venkataram Prasad BV; Palzkill T
Commun Biol; 2023 Jan; 6(1):35. PubMed ID: 36635385
[TBL] [Abstract][Full Text] [Related]
31. Natural Variants of the KPC-2 Carbapenemase have Evolved Increased Catalytic Efficiency for Ceftazidime Hydrolysis at the Cost of Enzyme Stability.
Mehta SC; Rice K; Palzkill T
PLoS Pathog; 2015 Jun; 11(6):e1004949. PubMed ID: 26030609
[TBL] [Abstract][Full Text] [Related]
32. An active site loop toggles between conformations to control antibiotic hydrolysis and inhibition potency for CTX-M β-lactamase drug-resistance enzymes.
Lu S; Hu L; Lin H; Judge A; Rivera P; Palaniappan M; Sankaran B; Wang J; Prasad BVV; Palzkill T
Nat Commun; 2022 Nov; 13(1):6726. PubMed ID: 36344533
[TBL] [Abstract][Full Text] [Related]
33. Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa.
Barnes MD; Taracila MA; Rutter JD; Bethel CR; Galdadas I; Hujer AM; Caselli E; Prati F; Dekker JP; Papp-Wallace KM; Haider S; Bonomo RA
mBio; 2018 Dec; 9(6):. PubMed ID: 30538183
[No Abstract] [Full Text] [Related]
34. SHV-129: A Gateway to Global Suppressors in the SHV β-Lactamase Family?
Winkler ML; Bonomo RA
Mol Biol Evol; 2016 Feb; 33(2):429-41. PubMed ID: 26531195
[TBL] [Abstract][Full Text] [Related]
35. Combination of Amino Acid Substitutions Leading to CTX-M-15-Mediated Resistance to the Ceftazidime-Avibactam Combination.
Compain F; Dorchène D; Arthur M
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941650
[TBL] [Abstract][Full Text] [Related]
36. Patterns of Epistasis between beneficial mutations in an antibiotic resistance gene.
Schenk MF; Szendro IG; Salverda ML; Krug J; de Visser JA
Mol Biol Evol; 2013 Aug; 30(8):1779-87. PubMed ID: 23676768
[TBL] [Abstract][Full Text] [Related]
37. Removal of the Side Chain at the Active-Site Serine by a Glycine Substitution Increases the Stability of a Wide Range of Serine β-Lactamases by Relieving Steric Strain.
Stojanoski V; Adamski CJ; Hu L; Mehta SC; Sankaran B; Zwart P; Prasad BV; Palzkill T
Biochemistry; 2016 May; 55(17):2479-90. PubMed ID: 27073009
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the global stabilizing substitution A77V and its role in the evolution of CTX-M β-lactamases.
Patel MP; Fryszczyn BG; Palzkill T
Antimicrob Agents Chemother; 2015 Nov; 59(11):6741-8. PubMed ID: 26282414
[TBL] [Abstract][Full Text] [Related]
39. Structural Insight into the Mechanism of Inhibitor Resistance in CTX-M-199, a CTX-M-64 Variant Carrying the S
Cheng Q; Xu C; Chai J; Zhang R; Wai Chi Chan E; Chen S
ACS Infect Dis; 2020 Apr; 6(4):577-587. PubMed ID: 31709791
[TBL] [Abstract][Full Text] [Related]
40. Effects on substrate profile by mutational substitutions at positions 164 and 179 of the class A TEM(pUC19) beta-lactamase from Escherichia coli.
Vakulenko SB; Taibi-Tronche P; Tóth M; Massova I; Lerner SA; Mobashery S
J Biol Chem; 1999 Aug; 274(33):23052-60. PubMed ID: 10438473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
